Serotonin: A review

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 3, 2008, Pages 187-199

  Mohammad Zadeh, L F ^a   Moses, L ^b   Gwaltney Brant, S M ^c  

^a Southern Arizona Veterinary Specialty and Emergency Center   (United States)

^b ANGELL ANIMAL MEDICAL CENTER   (United States)

^c Animal Poison Control Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRAZ; AMITRIPTYLINE; AMPHETAMINE; BROMOCRIPTINE; BUSPIRONE; CHLORPROMAZINE; CISAPRIDE; CITALOPRAM; CLOMICALM; CYPROHEPTADINE; DEXTROMETHORPHAN; DOLASETRON MESILATE; FENTANYL; FLUOXETINE; FLUVOXAMINE; GLYCERYL TRINITRATE; KETANSERIN; LEVODOPA; LYSERGIDE; METOCLOPRAMIDE; ONDANSETRON; PAROXETINE; PROPRANOLOL; RECONCILE; SELEGILINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN; TRAMADOL; TRYPTOPHAN; UNINDEXED DRUG; YOHIMBINE;

BLOOD VESSEL TONE; DRUG MEGADOSE; DRUG TOXICITY; GASTROINTESTINAL MOTILITY; HUMAN; HYPERTENSION; IRRITABLE COLON; MIGRAINE; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM; THROMBOCYTE FUNCTION; VOMITING;

ANIMALS; GASTROINTESTINAL MOTILITY; HUMANS; PLATELET AGGREGATION; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN SYNDROME; VETERINARY MEDICINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 43549098999     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00944.x     Document Type: Review

References (95)

1. Amin, A., Crawford, T. Gaddum, J. (1954) The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. Journal of Physiology, 126, 596 618.
2. Andrews, P., Rapeport, W. Sanger, G. (1988) Neuropharmacology of emesis induced by anti-cancer therapy. Trends in Pharmacological Sciences, 9, 334 341.
3. Bamigbade, T., Davidson, S., Langford, R. Stamford, J. (1997) Actions of Tramadol, its enantiomers and principal metabolite, O-methyltramadol, on serotonin efflux and uptake in the rat dorsal raphe nucleus. British Journal of Anaesthesia, 79, 352 356.
4. Belohlavkova, S., Simak, J., Kokesova, A., Hnilickova, O. Hampl, V. (2001) Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. Journal of Applied Physiology, 91, 755 761.
5. Bolt, G. Saxena, P. (1985) Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit. Hypertension, 7, 499 506.
6. Boyer, E. Shannon, M. (2005) The Serotonin Syndrome. New England Journal of Medicine, 352, 1112 1120.
7. Brodie, B. Shore, P. (1957) A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Annals of the New York Academy of Sciences, 66, 631 642.
8. Brown, T. Skop, B. (1996) Nitroglycerine in the treatment of the serotonin syndrome. Annals of Pharmacotherapy, 30, 191.
9. Brown, T., Skop, B. Mareth, T. (1996) Pathophysiology and management of the serotonin syndrome. Annals of Pharmacotherapy, 30, 527 533.
10. Cerrito, F. Raiteri, M. (1979) Serotonin release is modulated by presynaptic autoreceptors. European Journal of Pharmacology, 57, 427 430.
11. Cerrito, F., Lazzaro, M., Gaudio, E., Arminio, P. Aloisi, G. (1993) 5-HT2-receptors and serotonin release: their role in human platelet aggregation. Life Science, 53, 209 215.
12. Champier, J., Claustrat, B., Besancon, R., Eymin, C., Killer, C., Jouvet, A., Chamba, G. Fevre-Montange, M. (1997) Evidence for tryptophan hydroxylase and hydroxy-indol-O-methyl-transferase mRNAs in human blood platelets. Life Science, 60, 2191 2197.
13. Clark, C., Weissbach, H. Udenfriend, S. (1954) 5-hydroxytryptophan decarboxylase: preparation and properties. Journal of Biological Chemistry, 210, 139 148.
14. Codd, E., Shank, R., Schupsky, J. Raffa, R. (1995) Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. Journal of Pharmacology and Experimental Therapeutics, 274, 1263 1270.
15. Crowell, M. (2004) Role of serotonin in the pathophysiology of the irritable bowel syndrome. British Journal of Pharmacology, 141, 1285 1293.
16. Crowell-Davis, S., Seibert, L., Sung, W., Parthasarathy, V. Curtis, T. (2003) Use of clomipramine, alprazolam, and behavior modification for treatment of storm phobia in dogs. Journal of the American Veterinary Medical Association, 222, 744 748.
17. Dahlstrom, A. Fuxe, K. (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. Acta Physiologica Scandinavica, 62, 1 55.
18. De Winter, B., Boeckxstaens, G., De Man, J., Moreels, T., Schuurkes, J., Peeters, T., Herman, A. Pelckmans, P. (1999) Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. Gut, 45, 713 718.
19. DeClerk, F. (1990) The role of serotonin in thrombogenesis. Clinical Physiology and Biochemistry, 8 (Suppl. 3 40 49.
20. Derkach, V., Surprenant, A. North, R. (1989) 5-HT3 receptors are membrane ion channels. Nature, 339, 706 709.
21. Dunkley, E., Isbister, G., Sibbritt, D., Dawson, A. Whyte, I. (2003) The Hunter serotonin toxicity criteria: simple and accurate diagnostic rules for serotonin toxicity. Quarterly Journal of Medicine, 96, 635 642.
22. Eddahibi, S., Hanoun, N., Lanfumey, L., Lesch, K., Raffestin, B., Hamon, M. Adnot, S. (2000) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. Journal of Clinical Investigation, 105, 1555 1562.
23. Eison, A., Eison, M., Stanley, M. Riblet, L. (1986) Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacology, Biochemistry, and Behavior, 24, 701 707.
24. Erspamer, V. Asero, B. (1952) Identification of enteramine, specific hormone of enterochromaffin cells, as 5-hydroxytryptamine. Nature, 169, 800 801 (Note: the original 1937 paper describing enteramine is written in Italian).
25. Frank, D., Gauthier, A. Bergeron, R. (2006) Placebo-controlled double-blind clomipramine trial for the treatment of anxiety or fear in beagles during ground transport. Canadian Veterinary Journal, 47, 1102 1108.
26. Garay, B., Mesa Plaza, N., Castilla Castellano, V. Dhimes Tejada, P. (2002) Serotonin syndrome: report of a fatal case and review of the literature. Revista Clinica Espanola, 202, 209 211.
27. Gillman, P. (1996) Successful treatment of serotonin syndrome with chlorpromazine. Medical Journal of Australia, 165, 345.
28. Gillman, P. (2005) Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 95, 434 441.
29. Graham, P. (1997) Successful treatment of the toxic serotonin syndrome with chlorpromazine. Medical Journal of Australia, 166, 166 167.
30. Graudins, A., Stearman, A. Chan, B. (1998) Treatment of the serotonin syndrome with cyproheptadine. Journal of Emergency Medicine, 16, 615 619.
31. Grider, J., Foxx-Orenstein, A. Jin, J. (1998) 5-Hydroxytryptamine 4 receptor agonist initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology, 115, 370 380.
32. Gwaltney-Brant, S., Albretsen, J. Khan, S. (2000) 5-hydroxytryptophan toxicosis in dogs: 21 cases (1989-1999). Journal of the American Veterinary Medical Association, 216, 1937 1940.
33. Hardisty, R. Stacey, R. (1955) Five-hydroxtryptamine in normal human platelets. Journal of Physiology, 130, 711 720.
34. Hart, B., Cliff, K., Tynes, V. Bergman, L. (2005) Control of urine marking by use of long-term treatment with fluoxetine or clomipramine in cats. Journal of the American Veterinary Medical Association, 226, 378 382.
35. Hergovich, N., Aigner, M., Eichler, H., Entlicher, J., Drucker, C. Jilma, B. (2000) Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clinical Pharmacology and Therapeutics, 68, 435 442.
36. Hesketh, P. Gandara, D. (1991) Serotonin antagonists: a new class of antiemetic agents. Journal of the National Cancer Institute, 83, 613 620.
37. Hess, R., Kass, P. Winkle, T. (2003) Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs. Journal of Veterinary Internal Medicine, 17, 489 494.
38. 3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. British Journal of Pharmacology, 97, 247 255.
39. Hilton, B. Cumings, N. (1971) As assessment of platelet aggregation induced by 5-hydroxytryptamine. Journal of Clinical Pathology, 24, 250 258.
40. Hoyer, D., Clarke, D., Fozard, J., Hartig, P., Martin, G., Mylecharane, E., Saxena, P. Humphrey, P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine. Pharmacology Review, 46, 157 203.
41. Humphrey, J. Jaques, R. (1954) The histamine and serotonin content of the platelets and polymorphonuclear leucocytes of various species. Journal of Physiology, 124, 305 310.
42. Janeway, T., Richardson, H. Park, E. (1918) Experiments on the vasoconstrictor action of blood serum. Archives of Internal Medicine, 21, 565 571.
43. Kandel, E. (2001) Depression, mania and anxiety disorders. In Principles of Neural Science, 4th edn. Eds Kandel, E., Schwartz, J. Jessell, T., pp. 1209 1225. McGraw-Hill, New York.
44. Kapur, S., Zipursky, R., Jones, C., Wilson, A., Dasilva, J. Houle, S. (1997) Cyproheptadine: a potent in vivo serotonin antagonist. American Journal of Psychiatry, 154, 884 885.
45. Katzung, B. (2001) Editor. Basic and Clinical Pharmacology, 8th edn. McGraw-Hill, San Francisco.
46. Kii, Y., Nakatsuji, K., Nose, I., Yabuuchi, M., Mizuki, Y. Ito, T. (2001) Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats. Pharmacology and Toxicology, 89, 96 103.
47. King, J., Simpson, B., Overall, K., Overall, K., Appleby, D., Pageat, P., Ross, C., Chaurand, J., Heath, S., Beata, C., Weiss, A., Muller, G., Paris, T., Bataille, B, Parker, J, Petit, S. Wren, J. (2000) Treatment of separation anxiety in dogs with clomipramine: results from a prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial. Applied Animal Behaviour Science, 67, 255 275.
48. Kitson, R. Carr, B. (2005) Tramadol and severe serotonin syndrome. Anaesthesia, 60, 934 935.
49. Lappin, R. Auchincloss, E. (1994) Treatment of the serotonin syndrome with cyproheptadine. New England Journal of Medicine, 331, 1021 1022.
50. Liu, S., Tilley, L., Tappe, J. Fox, P. (1986) Clinical and pathological findings in dogs with atherosclerosis: 21 cases (1970-1983). Journal of the American Veterinary Medical Association, 189, 227 232.
51. Marcos, E., Adnot, S., Pham, M., Nosjean, A., Raffestin, B., Hamon, M. Eddahibi, S. (2003) Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine, 168, 487 493.
52. McIsaac, W. Page, I. (1959) The metabolism of serotonin (5-hydroxytryptamine). Journal of Biological Chemistry, 234, 858 864.
53. Michaelson, I. Whittaker, V. (1963) The subcellular localization of 5-hydroxytryptamine in guinea pig brain. Biochemical Pharmacology, 12, 203 211.
54. Mitchell, J. Sharp, A. (1964) Platelet clumping in vitro. British Journal of Haematology, 10, 78 93.
55. Morrell, C., Volk, V. Mankowski, J. (2002) A carcinoid tumor in the gallbladder of a dog. Veterinary Pathology, 39, 756 758.
56. Ni, W. Watts, S. (2006) 5-Hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clinical and Experimental Pharmacology and Physiology, 33, 575 583.
57. Nisijima, K., Yoshino, T., Yui, K. Katoh, S. (2001) Potent serotonin (5-HT) receptor antagonists completely prevent the 2A development of hyperthermia in an animal model of the 5-HT syndrome. Brain Research, 890, 23 31.
58. Noble, M. Drake-Holland, A. (1990) Evidence for a role of serotonin in initiation of coronary arterial thrombosis in dog and man. Clinical Physiology and Biochemistry, 8 (Suppl. 3 50 55.
59. Noguchi, T., Nishino, M. Kido, R. (1973) Tryptophan 5-hydroxylase in rat intestine. Biochemical Journal, 131, 375 380.
60. O'Brien, J. (1964) A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. Journal of Clinical Pathology, 17, 275 281.
61. O'Callaghan, D. Gaine, S. (2007) Combination therapy and new types of agents for pulmonary arterial hypertension. Clinics in Chest Medicine, 28, 169 185.
62. Ottervanger, J., Stricker, B., Huls, J. Weeda, J. (1994) Bleeding attributed to the intake of paroxetine. American Journal of Psychiatry, 151, 781 782.
63. Overall, K. Dunham, A. (2002) Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989-2000). Journal of the American Veterinary Medical Association, 221, 1445 1452.
64. Owens, M.J. (1996) Molecular and cellular mechanisms of antidepressant drugs. Depression and Anxiety, 4, 153 159.
65. Page, I. McCubbin, J. (1953) The variable arterial pressure response to serotonin in laboratory animals and man. Circulation Research, 1, 354 362.
66. Peroutka, S. Howell, T. (1994) The molecular evolution of G protein-coupled receptors. Neuropharmacology, 33, 319 324.
67. Plumb, DC (Ed 2002) Veterinary Drug Handbook, 4th edn. Iowa State Press. Ames, Iowa.
68. Pryor, P., Hart, B., Cliff, K. Bain, M. (2001) Effects of a selective serotonin reuptake inhibitor on urine spraying behavior in cats. Journal of the American Veterinary Medical Association, 219, 1557 1561.
69. Rapport, M., Green, A. Page, I. (1948a) Crystalline serotonin. Science, 108, 329 330.
70. Rapport, M., Green, A. Page, I. (1948b) Partial purification of the vasoconstrictor in beef serum. Journal of Biological Chemistry, 174, 735 741.
71. Rapport, M., Green, A. Page, I. (1948c) Serum vasoconstrictor IV. Isolation and characterization. Journal of Biological Chemistry, 176, 1243 1251.
72. Reid, G. Bick, M. (1942) Pharmacologically active substances in serum. Australian Journal of Experimental Biology and Medical Science, 20, 33 46.
73. Reid, G. Rand, M. (1952) Pharmacological actions of synthetic 5-hydroxytryptamine. Nature, 169, 801 802.
74. Sandler, M., Reveley, M. Glover, V. (1981) Human platelet monoamine oxidase activity in health and disease: a review. Journal of Clinical Pathology, 34, 292 302.
75. Saxena, P., Bolt, G. Dhasmana, K. (1987) Serotonin agonists and antagonists in experimental hypertension. Journal of Cardiovascular Pharmacology, 10 (Suppl. 3 S12 S18.
76. Simpson, B. Papich, M. (2003) Pharmacologic management in veterinary behavioral medicine. Veterinary Clinics of North America. Small Animal Practice, 33, 365 404.
77. Simpson, B. Simpson, D. (1996) Behavioral pharmacotherapy. Part I. Antipsychotics and antidepressants. Compendium for the Continuing Education of the Practicing Veterinarian, 18, 1067 1081.
78. Simpson, B., Landsberg, G., Reisner, I. et al. (2007) Effects of Reconcile (fluoxetine) chewable tablets plus behavior management for canine separation anxiety. Veterinary Therapeutics, 8, 18 31.
79. Skop, B. Brown, T. (1996) Potential vascular bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics, 37, 12 16.
80. Skop, B., Finkelstein, J., Mareth, T., Magoon, M. Brown, T. (1994) Serotonin syndrome associated with paroxetine, an OTC cold remedy, and vascular disease. American Journal of Emergency Medicine, 12, 642 644.
81. Sneddon, J. (1973) Blood platelets as a model for monoamine-containing neurones. Progress in Neurobiology, 1, 151 198.
82. Sottiaux, J. (1999) Atherosclerosis in a dog with diabetes mellitus. Journal of Small Animal Practice, 40, 581 584.
83. Sternbach, H. (1991) The serotonin syndrome. American Journal of Psychiatry, 148, 705 813.
84. Toh, C. (1954) Release of 5-hydroxytryptamine from the dog's gastrointestinal tract. Journal of Physiology, 126, 248 254.
85. Tong, J. Kaufman, S. (1975) Tryptophan hydroxylase. Purification and some properties of the enzyme from rabbit hindbrain. Journal of Biological Chemistry, 250, 4152 4158.
86. Torres, G., Gainetdinov, R. Caron, M. (2003) Plasma membrane monoamine transporters: structure, regulation and function. Neuroscience, 4, 13 26.
87. Trulson, M. Arasteh, K. (1986) Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in-vitro. Journal of Pharmacy and Pharmacology, 38, 380 382.
88. Twarog, B. Page, I 1953) Serotonin content of some mammalian tissues and urine and a method for its determination. American Journal of Physiology, 175, 157 161.
89. Tyce, G. (1990) Origin and metabolism of serotonin. Journal of Cardiovascular Pharmacology, 16 (Suppl. 3 S1 S7.
90. Van Den Berg, L., Versteeg, S. Van Oost, B. (2003) Isolation and characterization of the canine serotonin receptor 1A gene (htr 1A). Journal of Heredity, 94, 49 56.
91. Vanhoutte, P. (1987) Cardiovascular effects of serotonin. Journal of Cardiovascular Pharmacology, 10 (Suppl. 3 S8 S11.
92. Vanhoutte, P. (1990) Vascular effects of serotonin and ischemia. Journal of Cardiovascular Pharmacology, 16 (Suppl. 3 S15 S19.
93. Wilson, D., Evans, A. Mauer, W. (2006) Influence of metoclopramide on gastroesophageal reflux in anesthetized dogs. American Journal of Veterinary Research, 67, 26 31.
94. Zieher, L. DeRobertis, E. (1963) Subcellular localization of 5-hydroxytryptamine in rat brain. Biochemical Pharmacology, 12, 596 598.
95. Zucker, M. (1944) A study of the substances in blood serum and platelets which stimulate smooth muscle. American Journal of Physiology, 142, 12 26.